Repository logo
 
Publication

Red blood cell membrane-camouflaged gold-core silica shell nanorods for cancer drug delivery and photothermal therapy

dc.contributor.authorRodrigues, Ana Carolina F.
dc.contributor.authorCorreia, I.J.
dc.contributor.authorMoreira, André F.
dc.date.accessioned2024-03-25T15:10:25Z
dc.date.available2024-03-25T15:10:25Z
dc.date.issued2024-03-15
dc.description.abstractGold core mesoporous silica shell (AuMSS) nanorods are multifunctional nanomedicines that can act simultaneously as photothermal, drug delivery, and bioimaging agents. Nevertheless, it is reported that once administrated, nanoparticles can be coated with blood proteins, forming a protein corona, that directly impacts on nanomedicines’ circulation time, biodistribution, and therapeutic performance. Therefore, it become crucial to develop novel alternatives to improve nanoparticles’ half-life in the bloodstream. In this work, Polyethylenimine (PEI) and Red blood cells (RBC)-derived membranes were combined for the first time to functionalize AuMSS nanorods and simultaneously load acridine orange (AO). The obtained results revealed that the RBC 41 derived membranes promoted the neutralization of the AuMSS’ surface charge and consequently improved the colloidal stability and biocompatibility of the nanocarriers. Indeed, the in vitro data revealed that PEI/RBC-derived membranes’ functionalization also improved the nanoparticles’ cellular internalization and was capable of mitigating the hemolytic effects of AuMSS and AuMSS/PEI nanorods. In turn, the combinatorial chemo-photothermal therapy mediated by AuMSS/PEI/RBC_AO nanorods was able to completely eliminate HeLa cells, contrasting with the less efficient standalone therapies. Such data reinforce the potential of AuMSS nanomaterials to act simultaneously as photothermal and chemotherapeutic agents.pt_PT
dc.description.versioninfo:eu-repo/semantics/acceptedVersionpt_PT
dc.identifier.doi10.1016/j.ijpharm.2024.124007pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.6/14319
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevierpt_PT
dc.relationHealth Sciences Research Centre
dc.relationHealth Sciences Research Centre
dc.relationSilk Sericin as an industrial wastewater with valuable biomedical potential
dc.relationDevelopment of multifunctional Gold Core Silica Shell nanomedicines for the immune/chemo/photothermal therapy of breast cancer
dc.relationAssociate Laboratory of Energy, Transports and Aeronautics
dc.relationAssociate Laboratory of Energy, Transports and Aeronautics
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0378517324002412pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/pt_PT
dc.subjectCancerpt_PT
dc.subjectDrug deliverypt_PT
dc.subjectGold core silica shell nanorodspt_PT
dc.subjectPhotothermal therapypt_PT
dc.subjectPEIpt_PT
dc.subjectRBC-derived membranespt_PT
dc.titleRed blood cell membrane-camouflaged gold-core silica shell nanorods for cancer drug delivery and photothermal therapypt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleHealth Sciences Research Centre
oaire.awardTitleHealth Sciences Research Centre
oaire.awardTitleSilk Sericin as an industrial wastewater with valuable biomedical potential
oaire.awardTitleDevelopment of multifunctional Gold Core Silica Shell nanomedicines for the immune/chemo/photothermal therapy of breast cancer
oaire.awardTitleAssociate Laboratory of Energy, Transports and Aeronautics
oaire.awardTitleAssociate Laboratory of Energy, Transports and Aeronautics
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00709%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F00709%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FBTA-BTA%2F0696%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/2022.06320.PTDC/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F144680%2F2019/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F50022%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50022%2F2020/PT
oaire.citation.conferencePlaceHolandapt_PT
oaire.citation.startPage124007pt_PT
oaire.citation.titleInternational Journal of Pharmaceuticspt_PT
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream3599-PPCDT
oaire.fundingStream3599-PPCDT
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
person.familyNameFélix Rodrigues
person.familyNameJoaquim Sobreira Correia
person.familyNameMoreira
person.givenNameAna Carolina
person.givenNameIlídio
person.givenNameAndré Ferreira
person.identifierUMbJ1KMAAAAJ
person.identifier1161643
person.identifier.ciencia-id3D14-BE84-E5CD
person.identifier.ciencia-idF610-7373-DC81
person.identifier.ciencia-id4C1E-012B-83CE
person.identifier.orcid0000-0002-5493-8331
person.identifier.orcid0000-0003-1613-9675
person.identifier.orcid0000-0002-0604-2506
person.identifier.scopus-author-id57202076016
person.identifier.scopus-author-id7003557499
person.identifier.scopus-author-id56401521300
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication5c78ad01-afa8-470c-b674-0892eeed6534
relation.isAuthorOfPublicationf2c3e779-34a2-4309-950a-80687664c6ad
relation.isAuthorOfPublicatione20bf724-86f1-4fc8-800d-39ff19b624b1
relation.isAuthorOfPublication.latestForDiscoveryf2c3e779-34a2-4309-950a-80687664c6ad
relation.isProjectOfPublicationc7cee677-067c-47b2-ab19-b2dd5b0fda9d
relation.isProjectOfPublicationa4dfaeb8-2685-4a99-ba26-acc4e4a3d7c5
relation.isProjectOfPublication4fc0dde5-ddef-4636-8262-d3d88b5c7f91
relation.isProjectOfPublication2bf95b58-afb8-47de-b244-87acb0dd73d1
relation.isProjectOfPublication5b76944e-3750-4bb4-8eee-0105aa9d6f3f
relation.isProjectOfPublication537bf50b-b9fe-4a1d-ace4-7e64c86ebe14
relation.isProjectOfPublicationd3f48e72-49da-44e7-b054-cbdb0644e04d
relation.isProjectOfPublication.latestForDiscovery2bf95b58-afb8-47de-b244-87acb0dd73d1

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
2024 Carolina IJP.pdf
Size:
5.5 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: